NeoPhore Company

NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.

Headquarters: Cambridge, Cambridgeshire, United Kingdom
Funding Status: N/A
Employee Number: Undisclosed
Investment Stage: N/A
Number Of Exists: N/A
Technology: Drug Discovery
Investor Type: N/A
Founded Date: 2017
Industry: Preventive Medicine